121 related articles for article (PubMed ID: 27116852)
1. Promising results from cyclophosphamide based immunosuppression therapy of thrombotic thrombocytopenic purpura.
Guzicka-Kazimierczak R; Kazimierczak A; Clark J
Pomeranian J Life Sci; 2015; 61(1):34-40. PubMed ID: 27116852
[TBL] [Abstract][Full Text] [Related]
2. Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy.
Allan DS; Kovacs MJ; Clark WF
Haematologica; 2001 Aug; 86(8):844-50. PubMed ID: 11522541
[TBL] [Abstract][Full Text] [Related]
3. Oral cyclophosphamide for refractory or relapsing thrombotic thrombocytopenic purpura (TTP).
Hertzberg MS; Koutts J
Aust N Z J Med; 1997 Aug; 27(4):439. PubMed ID: 9448886
[No Abstract] [Full Text] [Related]
4. Thrombotic thrombocytopenic purpura (TTP): initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases.
Yang CW; Chen YC; Dunn P; Chang MY; Fang JT; Huang CC
Ren Fail; 2003 Jan; 25(1):21-30. PubMed ID: 12617330
[TBL] [Abstract][Full Text] [Related]
5. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
Zheng X; Pallera AM; Goodnough LT; Sadler JE; Blinder MA
Ann Intern Med; 2003 Jan; 138(2):105-8. PubMed ID: 12529092
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Beloncle F; Buffet M; Coindre JP; Munoz-Bongrand N; Malot S; Pène F; Mira JP; Galicier L; Guidet B; Baudel JL; Subra JF; Tanguy-Schmidt A; Pourrat J; Azoulay E; Veyradier A; Coppo P;
Transfusion; 2012 Nov; 52(11):2436-44. PubMed ID: 22404639
[TBL] [Abstract][Full Text] [Related]
7. Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.
Wieland I; Kentouche K; Jentzsch M; Lothschütz D; Graf N; Sykora KW
Pediatr Blood Cancer; 2015 May; 62(5):823-9. PubMed ID: 25623397
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylcysteine for Relapsing Thrombotic Thrombocytopenic Purpura: More Evidence of a Promising Drug.
Cabanillas G; Popescu-Martinez A
Am J Ther; 2016; 23(5):e1277-9. PubMed ID: 26720166
[TBL] [Abstract][Full Text] [Related]
11. Summaries for patients. Treatment of refractory thrombotic thrombocytopenic purpura.
Ann Intern Med; 2003 Jan; 138(2):I38. PubMed ID: 12529111
[No Abstract] [Full Text] [Related]
12. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
[TBL] [Abstract][Full Text] [Related]
13. Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura.
Chen H; Fu A; Wang J; Wu T; Li Z; Tang J; Shen H; Zhu J; Li J; Zhu Q; Qing L
J Int Med Res; 2017 Jun; 45(3):1253-1260. PubMed ID: 28639502
[TBL] [Abstract][Full Text] [Related]
14. Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura.
Liu C; Kallogjeri D; Dynis M; Grossman BJ
Transfusion; 2013 May; 53(5):1096-107. PubMed ID: 22905833
[TBL] [Abstract][Full Text] [Related]
15. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.
Delmas Y; Helou S; Chabanier P; Ryman A; Pelluard F; Carles D; Boisseau P; Veyradier A; Horovitz J; Coppo P; Combe C
BMC Pregnancy Childbirth; 2015 Jun; 15():137. PubMed ID: 26081109
[TBL] [Abstract][Full Text] [Related]
16. Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience.
Öngören S; Salihoğlu A; Apaydın T; Sadri S; Eşkazan AE; Ar MC; Elverdi T; Başlar Z; Aydın Y; Soysal T
Balkan Med J; 2018 Nov; 35(6):417-421. PubMed ID: 29966997
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.
Patriquin CJ; Thomas MR; Dutt T; McGuckin S; Blombery PA; Cranfield T; Westwood JP; Scully M
Br J Haematol; 2016 Jun; 173(5):779-85. PubMed ID: 27009919
[TBL] [Abstract][Full Text] [Related]
18. Management of thrombotic thrombocytopenic purpura.
Coppo P;
Transfus Clin Biol; 2017 Sep; 24(3):148-153. PubMed ID: 28645643
[TBL] [Abstract][Full Text] [Related]
19. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
Goyal J; Adamski J; Lima JL; Marques MB
J Clin Apher; 2013 Dec; 28(6):390-4. PubMed ID: 23857472
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with CHOP for recurrent thrombotic thrombocytopenic purpura.
Spiekermann K; Wörmann B; Rumpf KW; Hiddemann W
Br J Haematol; 1997 Jun; 97(3):544-6. PubMed ID: 9207396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
